Adar1 Capital Management, LLC Clene Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
Shares
1 transactions
Others Institutions Holding CLNN
# of Institutions
6Shares Held
230KCall Options Held
0Put Options Held
25K-
Morgan Jess S & CO Inc112KShares$414,4000.27% of portfolio
-
Black Rock Inc. New York, NY83.5KShares$308,7680.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ25.2KShares$93,3510.0% of portfolio
-
Jefferies Group LLC New York, NY4.96KShares$18,3370.0% of portfolio
-
Cutler Group LP3.9KShares$14,4300.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $235M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...